Nuformix plc (LON:NFX – Get Free Report)’s stock price shot up 19.1% on Wednesday . The company traded as high as GBX 0.27 and last traded at GBX 0.27. Approximately 8,999,223 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 53,626,621 shares. The stock had previously closed at GBX 0.23.
Nuformix Stock Up 8.0%
The firm has a market cap of £5.13 million, a price-to-earnings ratio of -0.62 and a beta of 1.22. The stock’s 50 day moving average is GBX 0.30 and its 200 day moving average is GBX 0.18.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications.
Read More
- Five stocks we like better than Nuformix
- The boring AI play that could pay up to $4,290 monthly
- The gift that keeps giving (just $1 today)
- The Best $1 You’ll Spend This Holiday Season
- Trump’s “real estate deal for America” explained
- Trump Did WHAT??
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
